Kristian S.
Member of the Board at Toleranzia AB- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Swedish -
-
English -
Topline Score
Bio
Clive Jackson
I have worked closely with Kristian for about ten years. During much of that time I chaired the AstraZeneca Global Target Validation Network and Kristian represented the CNS and Pain Research Area on its leadership team, helping to established its objectives and mode of operation. He has been on the steering committee for major biotech collaborations in target validation technology involving co-ordination of studies across all research areas in AZ. He also led an initiative in new viral delivery technologies and has managing AZ TV Network post-doctoral workers. He actively lead user groups in the network to help disseminate technologies, All this was on top of his direct line responsibilities in the CNS and Pain Research Area where he is an experience target and drug discovery leader. Kristian is an authority in CNS and pain, he is passionate about advancing target validation and has led excellent science in collaborations and the TV Network. He is an excellent team player and co-worker and has great commitment to shared objectives and delivers what he sets out to do in a strongly collaborative way. Overall Kristian is an outstanding colleague and bioscientist. Clive Jackson
Clive Jackson
I have worked closely with Kristian for about ten years. During much of that time I chaired the AstraZeneca Global Target Validation Network and Kristian represented the CNS and Pain Research Area on its leadership team, helping to established its objectives and mode of operation. He has been on the steering committee for major biotech collaborations in target validation technology involving co-ordination of studies across all research areas in AZ. He also led an initiative in new viral delivery technologies and has managing AZ TV Network post-doctoral workers. He actively lead user groups in the network to help disseminate technologies, All this was on top of his direct line responsibilities in the CNS and Pain Research Area where he is an experience target and drug discovery leader. Kristian is an authority in CNS and pain, he is passionate about advancing target validation and has led excellent science in collaborations and the TV Network. He is an excellent team player and co-worker and has great commitment to shared objectives and delivers what he sets out to do in a strongly collaborative way. Overall Kristian is an outstanding colleague and bioscientist. Clive Jackson
Clive Jackson
I have worked closely with Kristian for about ten years. During much of that time I chaired the AstraZeneca Global Target Validation Network and Kristian represented the CNS and Pain Research Area on its leadership team, helping to established its objectives and mode of operation. He has been on the steering committee for major biotech collaborations in target validation technology involving co-ordination of studies across all research areas in AZ. He also led an initiative in new viral delivery technologies and has managing AZ TV Network post-doctoral workers. He actively lead user groups in the network to help disseminate technologies, All this was on top of his direct line responsibilities in the CNS and Pain Research Area where he is an experience target and drug discovery leader. Kristian is an authority in CNS and pain, he is passionate about advancing target validation and has led excellent science in collaborations and the TV Network. He is an excellent team player and co-worker and has great commitment to shared objectives and delivers what he sets out to do in a strongly collaborative way. Overall Kristian is an outstanding colleague and bioscientist. Clive Jackson
Clive Jackson
I have worked closely with Kristian for about ten years. During much of that time I chaired the AstraZeneca Global Target Validation Network and Kristian represented the CNS and Pain Research Area on its leadership team, helping to established its objectives and mode of operation. He has been on the steering committee for major biotech collaborations in target validation technology involving co-ordination of studies across all research areas in AZ. He also led an initiative in new viral delivery technologies and has managing AZ TV Network post-doctoral workers. He actively lead user groups in the network to help disseminate technologies, All this was on top of his direct line responsibilities in the CNS and Pain Research Area where he is an experience target and drug discovery leader. Kristian is an authority in CNS and pain, he is passionate about advancing target validation and has led excellent science in collaborations and the TV Network. He is an excellent team player and co-worker and has great commitment to shared objectives and delivers what he sets out to do in a strongly collaborative way. Overall Kristian is an outstanding colleague and bioscientist. Clive Jackson
Experience
-
Toleranzia AB
-
Sweden
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Member of the Board
-
Dec 2017 - Present
-
-
-
Karolinska Institutet
-
Sweden
-
Higher Education
-
700 & Above Employee
-
Research Fellow (affiliation)
-
May 2012 - Present
Scientific research of inflammatory mechanisms. Kristian is available at the Karolinska Institute on Fridays. Scientific research of inflammatory mechanisms. Kristian is available at the Karolinska Institute on Fridays.
-
-
-
Uppsala University
-
Sweden
-
Higher Education
-
700 & Above Employee
-
Director for the Drug Discovery and Development (DDD) platform Uppsala, SciLifeLab
-
Mar 2015 - Present
Together with the DDD platform Director at the Karolinska Institute, work to implement the DDD platform as a fully integrated partner for academic drug discovery research available to all scientists at Swedish Universities. For more information see: http://www.scilifelab.se/platforms/ddd/ Together with the DDD platform Director at the Karolinska Institute, work to implement the DDD platform as a fully integrated partner for academic drug discovery research available to all scientists at Swedish Universities. For more information see: http://www.scilifelab.se/platforms/ddd/
-
-
-
AstraZeneca
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Disease Area Expert - TI
-
Sep 2012 - Mar 2015
As part of the Translational Science Leadership Team, Kristian works on the development of the scientific strategy for the Respiratory & Inflammation (R&I) Innovative Medicine (iMED) unit, and as the operational leader drives its subsequent implementation on the level of target generation ensuring that business needs are effectively translated into a viable project portfolio. As part of the Translational Science Leadership Team, Kristian works on the development of the scientific strategy for the Respiratory & Inflammation (R&I) Innovative Medicine (iMED) unit, and as the operational leader drives its subsequent implementation on the level of target generation ensuring that business needs are effectively translated into a viable project portfolio.
-
-
-
AstraZeneca R&D, iMed CNSP
-
AstraZeneca R&D Södertälje, iMed CNSP
-
Project Generation Manager
-
Jan 2010 - Sep 2012
The Project Generation Manager is a leadership role in the AstraZeneca innovative Medicines organisation with operational accountability for the success of a group of Project Generation activities within one disease area. The responsibilities include: - build-up of the early discovery portfolio within the disease area - receive and evaluate new project ideas - deliver new projects for Target Selection decision, either for lead generation or to enter development phase for clinical studies - lead the Project Generation Team - lead one project in lead generation phase The job purpose is to manage and drive the pre-projects so that they fulfil high quality transition criteria, establish a “line of sight” to clinic, addressing the critical questions for each transition and keep to agreed timelines. Show less
-
-
-
-
Target Biology Leader
-
2006 - 2009
Coaching drug discovery scientists and project leaders in drug discovery research, especially concerning molecular pharmacology and target validation related questions. Point of contact at AstraZeneca R&D Södertälje concerning target validation related matters.
-
-
Target Strategy Coordinator
-
2001 - 2006
Coaching pre-project leaders and scientist in drug discovery concerning molecular pharmacology and target validation studies. Point of contact at AstraZeneca R&D Södertälje concerning target validation related matters.
-
-
-
AstraZeneca
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Scientist
-
1999 - 2001
Scientist - Project Team Leader/pre-Project Leader for Functional Genomics and early Lead Generation projects Scientist - Project Team Leader/pre-Project Leader for Functional Genomics and early Lead Generation projects
-
-
-
Astra Arcus AB
-
Dept. Neuroinflammation
-
Scientist
-
1994 - 1999
Scientist - Project Team Leader/pre-Project Leader for Functional Genomics and early Lead Generation projects, Astra Arcus AB Scientist - Project Team Leader/pre-Project Leader for Functional Genomics and early Lead Generation projects, Astra Arcus AB
-
-
-
Swedish University of Agricultural Sciences, Veterinary Faculty
-
Uppsala, Sweden
-
Assistant Professor
-
1991 - 1995
-
-
-
Scripps Research Institute, Dept. Neuropharmacology
-
La Jolla, CA ,USA
-
Research Fellow
-
1992 - 1993
-
-
Education
-
1991 - 1996
Swedish University of Agricultural Sciences
Assoc. Prof. "Docent", Immunology -
1996 - 1997
Astra Arcus AB
Project Leader -
1986 - 1991
Swedish University of Agricultural Sciences
PhD, Immunology -
1981 - 1985
Uppsala universitet
BSc, Life Science (Biology, Chemistry) -
1980 - 1981
Military Service
-
1977 - 1980
De La Gardieskolan, Lidköping
Life Sciences, Naturvetenskaplig linje
Community
